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Objective: This study was designed to evaluate a newly developed biologic valved
conduit fixed with genipin used to reconstruct the right ventricular outflow tract in
a canine model.
Methods: Fresh bovine jugular veins with a retained native valve procured from a
slaughterhouse were used as raw materials to fabricate the valved conduits. A natu-
rally occurring crosslinking agent, genipin, was used to fix the procured jugular
veins. The glutaraldehyde-fixed counterpart was used as a control. A canine model
was used in the study.
Results: Echocardiography revealed that the motion of the valvular leaflets in both the
glutaraldehyde- and genipin-fixed conduits was satisfactory. The transvalvular pres-
sure gradients of both studied groups were minimal. No endothelium-like cells were
observed on the luminal surface of the conduit and the valvular leaflet for the glu-
taraldehyde-fixed group throughout the entire course of the study. In contrast, endothe-
lium-like cells were observed on the entire surface of the genipin-fixed valved conduit
retrieved at 6 months postoperatively in all the cases studied. There was no evidence
of luminal fibrous peel in any the valved conduits studied. Degradation of valvular
leaflet in one of the glutaraldehyde-fixed conduits was observed. In this particular
case, thrombus formation was also observed on the surface of the valvular leaflet. On
the other hand, no apparent degradation or thrombus formation was observed on the
surfaces of the genipin-fixed valvular leaflet and conduit. A significantly more severe
inflammatory reaction was observed for the glutaraldehyde-fixed conduit than for its
genipin-fixed counterpart throughout the entire course of the study. The calcium con-
tents of the samples before implantation and those retrieved at distinct implantation
duration were minimal for both the glutaraldehyde- and genipin-fixed tissues.
Conclusion: Although further studies are necessary, the genipin-fixed valved con-
duit appears to have great potential in helping mitigate the complications observed
in the commercially available conduits.
There is a great medical need for the use of external valved conduitsin the repair of many congenital cardiac anomalies to reconstructthe right ventricular outflow tract (RVOT).1-9 Currently availablevalved conduits can be divided into 2 primary categories: allograftand xenograft. For the reconstruction of the RVOT, Homann andassociates9 reported that allografts show significantly better long-
term durability than xenografts, regardless of the age at implantation and the
diameter of the valved conduit. Although allografts are considered the conduit of
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choice, their availability is limited, and therefore
xenografts are implanted as well.9
The xenograft valved conduits currently available con-
sist of a synthetic Dacron graft with a tissue or mechanical
valve. Despite many endeavors in past decades, the clinical
results of RVOT reconstruction with these xenograft
valved conduits are still not satisfactory. Specific problems
encountered clinically include suboptimal hemodynamic
performance and conduit kinking or compression.5-7 In
addition, fibrous peeling from the Dacron graft, which
eventually results in valve dysfunction, has been reported
previously.5,7
To address these deficiencies, we undertook the develop-
ment of a new biologic valved conduit: a bovine jugular vein
graft with a retained native valve crosslinked with a natu-
rally occurring crosslinking agent, genipin. The retained
native valve in the bovine jugular vein used in the study had
2 leaflets. Trileaflet valvular configuration can also be
obtained in these natural conduits.
Clinically, the most commonly used crosslinking agent
for biologic tissue fixation is glutaraldehyde.10 However,
concerns exist regarding calcification, cytotoxicity, and
long-term durability with the currently available glutaralde-
hyde-fixed bioprostheses.11-14 In an attempt to overcome
these problems, our group has used a naturally occurring
crosslinking agent, genipin, to fix biologic tissues.15-18
Genipin and its related iridoid glucosides extracted from
the fruits of Gardenia jasminoides Ellis have been widely
used as an antiphlogistics and cholagogues in herbal medi-
cine.19 Additionally, genipin can spontaneously react with
amino acids or proteins to form dark-blue pigments.20,21
These dark-blue pigments have been used in the fabrication
of food dyes. The cytotoxicity of genipin was previously
studied by our group in vitro with 3T3 fibroblasts.17
Glutaraldehyde was used as a control. The results implied
that genipin is significantly less cytotoxic than glutaralde-
hyde. Additionally, the genotoxicity of genipin was tested in
vitro with Chinese hamster ovary (CHO-K1) cells.18 The
results hinted that glutaraldehyde may produce a weakly
clastogenic response in CHO-K1 cells. In contrast, genipin
does not cause a clastogenic response in CHO-K1 cells.
The biocompatibility of the genipin-fixed tissue was
studied in a growing rat model subcutaneously.16 It was
noted that the inflammatory reaction of the genipin-fixed
tissue was significantly less than that of its glutaraldehyde-
fixed counterpart. Furthermore, the calcium content of the
genipin-fixed tissue measured throughout the entire course
of the study was minimal. This implied that genipin may
form biocompatible crosslinked products. The aforemen-
tioned results indicated that genipin is an effective
crosslinking agent for biologic tissue fixation.
This study was designed to evaluate the performance of
this newly developed biologic valved conduit fixed with
genipin to reconstruct the RVOT in a canine model. The glu-
taraldehyde-fixed counterpart was used as a control.
Materials and Methods
Preparation of the Valved Conduits
Fresh bovine jugular veins (approximately 14-16 mm) with a
retained native valve procured from a slaughterhouse were used as
raw materials to fabricate the valved conduits tested in the study.
The procured bovine jugular veins were transported in a cold nor-
mal saline solution. On return, the jugular veins first were gently
rinsed with fresh saline solution to remove excess blood on the tis-
sue. Adherent fat was then carefully trimmed from the tissue sur-
face. Subsequently, a column of saline solution in a pressure of
approximately 10 mm Hg was filled into the jugular vein from its
distal end to check the valve competency. Only those jugular veins
with a competent valve were used in the study.
The jugular veins then were mounted onto a fixation tank. The
fixation tank was filled with a 0.625% aqueous glutaraldehyde or a
0.625% aqueous genipin (Challenge Bioproducts Co, Taichung,
Taiwan) solution buffered with phosphate-buffered saline solution
(pH 7.4) at room temperature. The mounted vein was fixed with its
valve closed by applying a 10–mm Hg column of fixation solution
into the conduit from its distal end. It was found in our study that the
retained valves in the bovine jugular veins were at times incompe-
tent when a zero or minimal pressure (2-3 mm Hg) was applied on
the valves during fixation. A 10–mm Hg pressure was therefore
applied on the valves during fixation to ensure that the retained
valves in the bovine jugular veins were competent in a physiologic
environment. The fixation solution was circulated through the vein
through its proximal end for about 15 minutes every 3 to 4 hours.
The fixation process was accomplished as per this procedure repet-
itively for 3 days. The maximum time period between retrieval and
initiation of tissue fixation was less than 6 hours.
The fixed valved conduits were sterilized in a graded series of
ethanol solutions, with a gradual increase in concentration from
20% to 75% over a period of 4 hours. Finally, the conduits were
rinsed in sterilized phosphate-buffered saline solution and pre-
pared for the animal study.
Implantation of the Valved Conduits
Sixteen mongrel dogs, each weighing about 20 to 25 kg, were used
in the study to evaluate the performance of the valved conduits pre-
pared. A left thoracotomy was performed through the fourth inter-
costal space after achievement of general anesthesia. An initial dose
of 100 U/kg body weight of heparin was administered. The RVOT
was partially clamped longitudinally, and an incision was made. The
proximal side-to-end anastomosis from the RVOT to the proximal
end of the conduit was completed with 5-0 polypropylene sutures by
using a continuous suturing technique. Then the proximal portion of
the conduit was clamped, and the clamp for the RVOT was released.
After the main pulmonary artery (PA) was partially clamped, sutur-
ing of the end-to-side distal anastomosis was made from the conduit
to the PA with continuous 6-0 polypropylene sutures. All clamps
were released, and the main PA was ligated between the anasto-
moses of the bypass conduit and distally to the native pulmonic
valve. No antithrombotic drugs were administered to the dogs after
the operation. Animal care and use was performed in compliance
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with the “Guide for the Care and Use of Laboratory Animals” pre-
pared by the Institute of Laboratory Animal Resources, National
Research Council, and published by the National Academy Press,
revised 1996.
Echocardiographic Examination
The functional and hemodynamic performance of the implanted
valved conduits was examined with an echocardiographic system
(HP Sonos 5500; Hewlett-Packard Company, Palo Alto, Calif).
Two-dimensional echocardiographic examination of the motion of
the valvular leaflets was conducted directly on the conduits imme-
diately after implantation and at retrieval with the animal during
general anesthesia. The peak transvalvular pressure gradient was
calculated from a simplified Bernoulli equation.22
Retrieval of the Implanted Valved Conduits
The implanted valved conduits were retrieved at 1 month (n = 4 for
each studied group) and 6 months (n = 4 for each studied group)
postoperatively. Before retrieval, the animals were given heparin.
At retrieval, the appearance of each retrieved valved conduit was
grossly examined. The retrieved conduits then were processed for
light microscopy for histologic examination or atomic absorption
analysis to determine calcium content.
Light Microscopy
All retrieved conduits were rinsed in physiologic saline solution to
remove excess blood. The samples used for light microscopy were
fixed in 10% phosphate-buffered formalin for at least 3 days and
prepared for histologic examination. In the histologic examination
the fixed samples were embedded in paraffin and sectioned into a
thickness of 5 µm and then stained with hematoxylin and eosin or
von Kossa stain. The stained sections of each test sample then were
examined with light microscopy (Nikon Microphoto-FXA) for tis-
sue inflammatory reaction (hematoxylin and eosin) and pho-
tographed with a 100 ASA Kodachrome film.
Atomic Absorption Analysis
The atomic absorption analysis was used to determine the cal-
cium content of each retrieved sample. In the analysis the
retrieved samples of each studied group first were lyophilized for
24 hours and weighed. The lyophilized sample then was
immersed in a 6N HCl solution (approximately 3 mg of
lyophilized tissue/3 mL of 6N HCl) and subsequently hydrolyzed
in a microwave hydrolysis system (MDS-2000; CEM Co,
Matthews, NC) for 45 minutes. Finally, the hydrolyzed sample
was diluted with a 5% lanthanum chloride in 3N HCl solution.
The calcium content of each test sample was determined by using
Figure 1. Two-dimensional echocardiographic images of the valvular leaflet motion of a genipin-fixed valved
conduit obtained at 6 months postoperatively: A, During opening; B, at closure.
A
B
Chang et al Surgery for Congenital Heart Disease



















an atomic absorption spectrophotometer (model AA-100; Perkin-
Elmer Inc, Norwalk, Conn) and was expressed as micrograms per
milligram of dry tissue weight.
The measurements of the denaturation temperature and tensile
strength of each test sample before implantation and at distinct
implantation duration were used to probe the potential susceptibil-
ity of each studied group to in vivo degradation.
Denaturation Temperature Measurement
The denaturation temperatures of each studied group before
implantation (taken from similarly fixed tissues that were unim-
planted) and those retrieved postoperatively were measured in a
Perkin-Elmer differential scanning calorimeter (model DSC-7).
This technique was widely used in studying the thermal transitions
of collagenous tissues.23 Details of the method used in the denatu-
ration temperature measurement were previously described.24
Tensile-Strength Measurement
The tensile strengths of each studied group before implantation
(taken from similarly fixed tissues that were unimplanted) and
those retrieved at distinct implantation duration were determined
by means of uniaxial measurements with an Instron material test-
ing machine (Mini 44; Canton, Mass) at a constant speed of 10
mm/min.
Statistical Analysis
Statistical analysis for the determination of differences in the mea-
sured properties between groups was accomplished with 1-way
analysis of variance and determination of CIs, which was per-
formed with a computer statistical program (Statistical Analysis
System, version 6.08; SAS Institute, Inc, Cary, NC). All data are
presented as mean values ± SD.
Results
Test Valved Conduits
In general, there was no significant difference in macro-
scopic observation between the genipin- and glutaralde-
hyde-fixed valved conduits besides the color. After fixation,
it was found that the color of the genipin-fixed valved con-
duit became dark bluish, whereas the glutaraldehyde-fixed
valved conduit turned yellowish.
Echocardiographic Examination
Echocardiography revealed that the motion of the valvular
leaflets in both the glutaraldehyde- and genipin-fixed con-
duits was satisfactory. Figure 1 presents representative 2-
dimensional echocardiographic images of the valvular leaflet
motion of a genipin-fixed conduit obtained at 6 months post-
Figure 2. Continuous-wave Doppler velocity spectrum obtained in an implanted genipin-fixed conduit at 6
months postoperatively.















D operatively. As shown, the 2 leaflets in the genipin-fixed con-
duit were fully open during opening (Figure 1, A) and
coapted tightly at closure (Figure 1, B). An example of the
continuous-wave Doppler velocity spectrum obtained in an
implanted genipin-fixed conduit at 6 months postoperatively
Surgery for Congenital Heart Disease Chang et al
is shown in Figure 2. The peak transvalvular pressure gradi-
ent measured by using a simplified Bernoulli equation was
approximately 4 mm Hg for both the glutaraldehyde- and
genipin-fixed conduits. No valvular regurgitation was
observed in any of the studied cases.
Figure 3. Photomicrographs of longitudinal sections of the glutaraldehyde- and genipin-fixed valved conduits
stained with hematoxylin and eosin and retrieved at 1 month postoperatively: A, Glutaraldehyde-fixed valved
conduit; B, genipin-fixed valved conduit.
A
B
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At retrieval, no cardiac failure or conduit kinking or com-
pression was observed in any of the studied cases. All con-
duits were patent, with the valves intact. Photomicrographs
of longitudinal sections of the glutaraldehyde- and
genipin-fixed valved conduits stained with hematoxylin
and eosin retrieved at 1 month postoperatively are pre-
sented in Figure 3. As shown, no significant degradation
was observed in the valvular leaflet and conduit for either
studied group.
Figure 4. Photomicrographs of longitudinal sections of the glutaraldehyde- and genipin-fixed valved conduits
stained with hematoxylin and eosin and retrieved at 6 months postoperatively: A, Glutaraldehyde-fixed valved
conduit; B, genipin-fixed valved conduit.
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Additionally, no thrombus formation was found on the
surfaces of the valvular leaflet and conduit in any of the stud-
ied cases. No signs of fibrous peeling on the surfaces of the
glutaraldehyde- and genipin-fixed conduits were observed.
The degrees of inflammatory reaction for the glutaralde-
hyde-fixed valvular leaflet and conduit appeared to be sig-
nificantly more severe than those of their genipin-fixed
counterparts. Of interest is that a thin layer of endothelium-
like cells formed smoothly on the surface of the genipin-
fixed conduit. However, there were no endothelium-like
cells present on the surface of the genipin-fixed valvular
leaflet at this time. In contrast, no endothelium-like cells
were found, either on the surface of the valvular leaflet or on
that of the conduit for the glutaraldehyde-fixed group.
At 6 months postoperatively, there was still no evidence of
luminal fibrous peel in all the valved conduits studied (Figure
4). Degradation of valvular leaflet in one of the glutaralde-
hyde-fixed conduits was observed (Figure 4, A). In this par-
ticular case, thrombus formation was also observed on the
surface of the valvular leaflet. On the other hand, no apparent
degradation or thrombus formation was observed on the sur-
faces of the genipin-fixed valvular leaflet and conduit. The
degrees of inflammatory reactions for the glutaraldehyde-
fixed valvular leaflet and conduit observed at 6 months post-
operatively were still rather severe. On the contrary, no
inflammatory cells were present in the genipin-fixed valvular
leaflet and conduit. Additionally, endothelium-like cells were
observed on the surfaces of both the genipin-fixed valvular
leaflet and conduit. In contrast, no endothelium-like cells
were observed on the surfaces of the valvular leaflet and con-
duit for the glutaraldehyde-fixed group. No significant dilata-
tion was present in any of the retrieved conduits.
Calcium Content
The calcium contents of the glutaraldehyde- and genipin-
fixed valvular leaflets before implantation and those
retrieved at 1 and 6 months postoperatively, quantified with
an atomic absorption spectrophotometer, are presented in
Figure 5. As shown, the calcium contents of the samples
before implantation and those retrieved at distinct implanta-
tion duration were minimal for both the glutaraldehyde- and
genipin-fixed tissues. The changes in calcium content for
both studied groups were not significant until 6 months
postoperatively (P < .05).
Denaturation Temperature and Tensile Strength
Figures 6 and 7 give the denaturation temperatures and the
tensile-strength values of the glutaraldehyde- and genipin-
fixed conduits before implantation and those retrieved at 1
and 6 months postoperatively. Generally, the denaturation
temperatures of both the glutaraldehyde- and genipin-fixed
conduits declined slightly as the duration of implantation
increased. However, the decline in denaturation temperature
for both studied groups was not significant (P > .05).
Although insignificant (P > .05), the tensile-strength values
of the retrieved glutaraldehyde-fixed conduits appeared to
be less than that of its genipin-fixed counterparts.
Discussion
Glutaraldehyde has been used extensively as a crosslinking
agent for fixing biologic tissues.10 By means of its aldehyde
functional groups, glutaraldehyde reacts primarily with the
ε-amino groups of lysyl or hydroxylysyl residues within
biologic tissues. The mechanism of fixation of biologic tis-
sues with glutaraldehyde can be found in the literature.10
Polymerization of glutaraldehyde molecules in aqueous
solution with observable reductions in free aldehyde have
Figure 5. Calcium contents of the glutaraldehyde- and genipin-
fixed valvular leaflets before implantation and those retrieved at
1 and 6 months postoperatively. The calcium content of each test
sample was determined by using an atomic absorption spec-
trophotometer and was expressed as micrograms per milligram of
dry tissue weight.
Figure 6. Denaturation temperatures of the glutaraldehyde- and
genipin-fixed conduits before implantation and those retrieved at
1 and 6 months postoperatively.
Chang et al Surgery for Congenital Heart Disease



















been reported previously.10,25 In polymerization the alde-
hyde functional groups of 2 glutaraldehyde molecules may
undergo an aldol condensation (Figure 8).10 With glu-
taraldehyde polymerization, subsequent to fixation, a net-
work crosslinking structure can be created intramolecularly
and intermolecularly within collagen fibers (Figure 8).
It was found, in our previous study,15 that genipin can
react with the free amino groups of lysine, hydroxylysine, or
arginine residues within biologic tissues. Touyama and col-
leagues20,21 studied the structures of the intermediates, lead-
ing to a blue pigment produced from genipin and
methylamine, the simplest primary amine. The presumed
mechanism for the formation of the genipin-methylamine
monomer and the blue-pigment polymers proposed by the
Touyama group can be found in the literature. Briefly speak-
ing, the genipin-methylamine monomer is formed though a
nucleophilic attack by methylamine on the olefinic carbon
at C-3 of genipin, followed by opening of the dihydropyran
ring and attack by the secondary amino group on the result-
ing aldehyde group (Figure 9, A).20,21 The blue-pigment
polymers are presumably formed through oxygen
radical–induced polymerization and dehydrogenation of
several intermediary pigments.
Similar results were also reported by Fujikawa and col-
leagues.26,27 In the study of the structure of a blue pigment
formed from glycine and genipin, the Fujikawa group found
multiple blue components. They reported that the simplest
component in the blue pigment was a 1:1 adduct. From the
structure of this simplest component, they proposed that
genipin reacts spontaneously with an amino acid to form a
nitrogen iridoid, which undergoes dehydration to form an
aromatic monomer. Dimerization occurs at the second
stage, perhaps by means of radical reaction. The results of
the aforementioned studies20,21,26,27 suggest that genipin
may form intramolecular and intermolecular crosslinks with
cyclic structure within collagen fibers in biologic tissue
(Figure 9, B).
In the study it was found that the transvalvular pressure
gradients of both the glutaraldehyde- and genipin-fixed
valved conduits were minimal (approximately 4 mm Hg)
compared with those of the currently available conduits and
were similar to those of the epoxy-fixed conduit reported in
the studies of Noishiki,28 Sung,29 Ichikawa,30 and their col-
leagues. No endothelium-like cells were observed on the
luminal surface of the conduit and the valvular leaflet for the
glutaraldehyde-fixed group throughout the entire course of
the study (≤6 months after implantation; Figures 3, A, and 4,
A). In contrast, endothelium-like cells were consistently
observed on the luminal surface of the genipin-fixed conduit
Figure 7. Tensile-strength values of the glutaraldehyde- and
genipin-fixed conduits before implantation and those retrieved at
1 and 6 months postoperatively.
Figure 8. Schematic illustration of the presumable intramolecular
and intermolecular crosslinking structures of the glutaraldehyde-
fixed tissue.
















near the valvular leaflet at 1 month postoperatively (Figure
3, B). Moreover, endothelium-like cells were observed on
the entire surface of the genipin-fixed valved conduit (both
the luminal surface and the valvular leaflet) retrieved at 6
months postoperatively in all the cases studied (Figure 4, B).
Endothelialization is one of the most promising mecha-
nisms to reduce thrombogenicity of any cardiovascular
implants.31,32 It was reported that the thrombogenicity of vas-
Surgery for Congenital Heart Disease Chang et al
cular implants can be significantly reduced by endothelial
cell lining of the luminal surface.33 In our study no thrombus
formation was observed on the surfaces of the luminal graft
and the valvular leaflet for the genipin-fixed group, whereas
thrombus formation was observed on the glutaraldehyde-
fixed valvular leaflet in one of the studied cases (Figure 4, A).
It was found, in an in vitro study,11 that the cytotoxicity of
epoxy compound is relatively less than that of glutaralde-
Figure 9. A, Presumable reaction mechanism of amino group with genipin.20,21 B, Schematic illustration of the
presumable intramolecular and intermolecular crosslinking structures of the genipin-fixed tissue.
A
B
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hyde. On the other hand, it was reported that genipin is sig-
nificantly less cytotoxic than glutaraldehyde and epoxy com-
pound.15,17 Host cells cannot migrate onto the cytotoxic area.
Therefore, no endothelium-like cells were observed on the
surfaces of the glutaraldehyde-fixed conduit and valvular
leaflet (Figures 3, A, and 4, A). However, endothelial cells
were found in the vicinity of the anastomoses of the epoxy-
fixed conduit reported on by Ichikawa and colleagues.30 In
contrast, host cells (endothelium-like cells) can migrate and
proliferate on the entire surface of the genipin-fixed valved
conduit because of its low cytotoxicity (Figure 4, B).
Similar results were found in an in vitro cell-culture
study conducted by our group.17 This indicated that the cel-
lular compatibility of the genipin-fixed tissue was superior
to its glutaraldehyde-fixed counterpart. Cytotoxicity of
residual glutaraldehyde released from the glutaraldehyde-
fixed tissue after implantation may also induce another
problem, foreign-body reaction. A significantly more severe
inflammatory reaction was observed for the glutaraldehyde-
fixed conduit than its genipin-fixed counterpart throughout
the entire course of the study (Figures 3, A and B, and 4, A
and B).
Degeneration was observed in the glutaraldehyde-fixed
leaflet retrieved at 6 months postoperatively in one of the
studied cases (Figure 4, A), whereas the genipin-fixed valvu-
lar leaflets stayed intact throughout the entire course of the
study. Additionally, the tensile-strength values of the
retrieved glutaraldehyde-fixed conduits appeared to be
slightly less than those of its genipin-fixed counterparts
(Figure 7). These facts indicated that the genipin-fixed tissue
may be more durable than its glutaraldehyde-fixed counter-
part. As shown in Figures 8 and 9, B, the cyclic crosslinking
structure of the genipin-fixed tissue may have a higher stereo-
hindrance for the penetration of enzymes than the network
crosslinking structure of the glutaraldehyde-fixed tissue
because of the bulky heterocyclic-structure of genipin. The
structure of stereohindrance may prevent enzymes from bind-
ing their corresponding substrates in biologic tissues.
Therefore, the genipin-fixed tissue appeared to be more
durable than its glutaraldehyde-fixed counterpart.
The calcium content of each studied group, analyzed
with atomic absorption, did not change significantly until 6
months postoperatively (Figure 5). Calcification in the glu-
taraldehyde-fixed bioprostheses has been commonly
reported clinically,10,13 but the data for the glutaraldehyde-
fixed conduit obtained in the present study did not indicate
this. Vyavahare and colleagues34 reported that ethanol pre-
treatment of the glutaraldehyde-fixed porcine aortic valve
inhibited calcification, resulting from protein structural
alterations and lipid extraction. The sterilant used in our
study for each implanted sample was a graded series of
ethanol solutions with a gradual increase in concentration.
Therefore, the inhibition of calcification for each implanted
test sample observed in our study may be due to the effect
of the ethanol sterilization process.
In conclusion, although further studies are necessary, the
genipin-fixed valved conduit appears to have great potential
in helping mitigate the complications observed in the com-
mercially available conduits.
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